Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Pharmacoidea Kft maintains a presence in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. The current prosecution activity involves 1 distinct examiner and 1 distinct art unit. This suggests a focused stage of portfolio management for the company's current applications.
The busiest examiner for this portfolio is PETRASH, HILARY ANN, who is responsible for 1 pending office action. This figure is equal to the total of 1 pending office action for the company. With the distinct art unit engaged, the prosecution is centralized within a technical group at the USPTO.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PETRASH, HILARY ANN | 1 | 64.5% | +51.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17311193 | BRAIN TARGETED DRUG DELIVERY METHOD VIA SYNDECAN-3 | PETRASH, HILARY ANN | 29d overdue |
| Art Unit | Apps |
|---|---|
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17311193 | BRAIN TARGETED DRUG DELIVERY METHOD VIA SYNDECAN-3 | PETRASH, HILARY ANN | 1644 | §112 | Final Rejection | 29d overdue | Pending | Jun 04, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial